EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS161-07812 
Organism
Homo sapiens 
Tissue/cell
PC3 
Coordinate
chr19:11263020-11264660 
TF binding sites/motifs
Number: 11             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr19:11263452-11263470AGGAGGAGGGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr19:11263456-11263474GGAGGGAAGGAGGGAAGA+6.96
HES2MA0616.2chr19:11264301-11264311GGCACGTGCC+6.02
HES2MA0616.2chr19:11264301-11264311GGCACGTGCC-6.02
MyogMA0500.1chr19:11263731-11263742CTGCAGCTGTC-6.62
Stat6MA0520.1chr19:11263758-11263773CGGTTCCTCAGAAAT+6.31
Tcf12MA0521.1chr19:11263731-11263742CTGCAGCTGTC-6.14
ZNF263MA0528.1chr19:11263443-11263464GGTGGAAGAAGGAGGAGGGAA+6.08
ZNF263MA0528.1chr19:11263447-11263468GAAGAAGGAGGAGGGAAGGAG+6.25
ZNF263MA0528.1chr19:11263450-11263471GAAGGAGGAGGGAAGGAGGGA+7.89
ZNF263MA0528.1chr19:11263453-11263474GGAGGAGGGAAGGAGGGAAGA+8.47
Number of super-enhancer constituents: 21             
IDCoordinateTissue/cell
SE_00404chr19:11263125-11264447Adipose_Nuclei
SE_01196chr19:11262904-11263938Adrenal_Gland
SE_01676chr19:11262885-11263954Aorta
SE_26153chr19:11262655-11264066Duodenum_Smooth_Muscle
SE_26820chr19:11262793-11264050Esophagus
SE_30142chr19:11263043-11263769Fetal_Muscle
SE_32185chr19:11262935-11264039Gastric
SE_34530chr19:11262880-11264181HCT-116
SE_35072chr19:11262705-11264160HeLa
SE_37121chr19:11262985-11264059HSMMtube
SE_38721chr19:11262930-11264050HUVEC
SE_40759chr19:11262874-11264168Left_Ventricle
SE_42281chr19:11262787-11264169Lung
SE_44509chr19:11262874-11263981NHDF-Ad
SE_44970chr19:11262874-11264161NHLF
SE_46645chr19:11263141-11263481Ovary
SE_47998chr19:11263067-11263894Pancreas
SE_48638chr19:11262872-11263957Right_Atrium
SE_49703chr19:11263046-11263582Right_Ventricle
SE_53189chr19:11263054-11263927Small_Intestine
SE_54664chr19:11262568-11264486Stomach_Smooth_Muscle
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr191126302411263792
chr191126432311264414
Enhancer Sequence
GATTACAGGC ATGCGCCACA ACGGCCAGCT AATTTTTGTA ATTTTAGTAG AGACCAGGTT 60
TCACCATGTT GACCAGGCTG GTCTTTAACT CCTGTCCTCA AGTGATTCAC CCACCTCGGC 120
CTCCCAAAAT GTTGAGATGA GAGGCGTGAG CCACCACACC CAGCCTGAGG GTGTACTTTA 180
ACTCCTCTGC CCCACATCTG TGACATGAAA AACAGGTCCA GAGACAGAAG TTCAGTGACT 240
CGCCCACAGG TACATAGCTC CAAACCTAGG ATGTGAACTG GATCTGTTTG ACCCAAAGCC 300
TAGGATCCCT GGATCCTGAT TCTCAGTTTT CTTGGCCCCA GATTCATCCA TTCTGCTAAC 360
AGCCAGGCTG GCCGAGTCAC ATCTTTCTCC TCAAGCCATC AAAGGAGGGG GAGTTAATGG 420
AGGGGTGGAA GAAGGAGGAG GGAAGGAGGG AAGAGCCTGC TTGGGACATC ACATTCAGGA 480
TAATATTCAG ACTCCTCCTG GGCACTCTCC AGGCCTGGCA GTCAGGCGGC TGCTGAGCTC 540
ATCTTCTGCT TGCCAAGTTC ATTCTCACCT CCTGACCTTT GCATTTGCAA TCCACGCTGC 600
CAGGAACACC GTTCCTGAGC CACCCCGTGG ACTGGCTCCA TAGGCCAATC AAGGCTCAGC 660
CCAGGCCTCC TCATAAAATG TGACTGTATA AGGCACCTGA AACCCCTGGC ACTGCAGCTG 720
TCAGGGAGAA CCGTATGGCG GTTCCTCAGA AATCAAACTT TGAATTACCA TTTGATCTGC 780
TTCTGGCTGA ATACAAAAAA GAACTGAAAA TAGAGTCTTG GCTGGGCGTG GTGGCTCACG 840
CCTGTAATCC CAGCACTTTG GGAGGTCGGG GCAGGTGGAT CACGAGGTCA GGAGATCGAG 900
ACCATCCTGG CTAACACGGT GAAACTCTGT CTCTACCAAA AAAAATACAA AAAAAAAATT 960
AGCCGGGCGT GGTGGCGGGT GCCTGTAGTC CCAGCTACTC GGGAGGCTGA GGCAGAATGG 1020
TGTGAACCCG GGAGACGGAG CTCGCAGTGA GCCAAGATCA CGCCACTGCA CTCCAGCCTG 1080
GGTGACAGAG CGAGACTCCA TATCAAAAAA ATAAAAAAAA GAAAATAGAG TCTTGGGCTG 1140
GGCGCAGTGG CTCATGCCTA TATTCCCAGC ACTTTGGGAG ACCGAGGCGG GCGGATCACG 1200
AGGTCAAGAG TTTGAGACCA GCCTGGCCAA CATGGTGAAA CCCCATCTTT ACTAAGAATA 1260
CAAAAATTAG CTGGGCATGT TGGCACGTGC CTGTAATCCC AGCTACTTGG CAGGCTGAGG 1320
CAGGAGAATT GCTTGAACCC AGGAGGCATA GGTCGCAGTG AGCAGAGATC ACGCTGCTGT 1380
ACTCCAGCCT GAGCAGCGGA GTAAGACTGT CCTGGGAAAA AAAAAAAAAA GAAGAAAATA 1440
TGGCTGGGCA CGGTGGCTCA TGCCTGTAAT CCCAGCACTT TGGGAGTCCG AGACGTGTGG 1500
ATCATGAGGT CAGGAGATCG AGACCATCCT GGCTAACACG GTGAAACCCC GTCTCTACTA 1560
AAAAAATATA TATAAAAATA TTAGCCGGGC GTGGTGGCGG GCACCTGTAG TCCCAGCTAC 1620
TCGGGAGGCT GAGGCAGGAG 1640